EMD SERONO, INC. for EMD SERONO INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
HR3221: FORECLOSURE PREVENTION ACT OF 2008; ACCELERATION OF R&D/AMT CREDITS (AS AMENDED BY SENATE) S3125: ENERGY INDEPENDENCE AND TAX RELIEF ACT OF 2008; SECTION 221-EXTENSION AND MODIFICATION RESEARCH CREDIT HR6049: RENEWABLE ENERGY AND JOB CREATION ACT OF 2008, R&D TAX CREDIT
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID NICHOLS | N/A |
| LYNN TAYLOR | N/A |
Copyright/Patent/Trademark CPT
HR 1908/S1145: PATENT REFORM ACT OF 2007; ALL PROVISIONS OF THE BILL
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID NICHOLS | N/A |
| LYNN TAYLOR | N/A |
Medicare/Medicaid MMM
HR2606/S1376: 340B PROGRAM IMPROVEMENT AND INTEGRITY ACT OF 2007; 340B DRUG PRICE EXPANSION HR3162: CHILDREN'S HEALTH AND MEDICARE PROTECTION ACT OF 2007; ALL PROVISIONS OF THE BILL HR4/S3: MEDICARE PRESCRIPTION DRUG PRICE NEGOTIATION ACT OF 2007; MEDICARE "NON-INTERFERENCE" PROVISIONS HR5480: MEDICARE FUNDING WARNING RESPONSE ACT OF 2008; ALL PROVISIONS OF THE BILL S2029: PHYSICIAN PAYMENT SUNSHINE ACT OF 2007; ALL PROVISIONS OF THE BILL S2662: MEDICARE FUNDING WARNING RESPONSE ACT OF 2008; ALL PROVISIONS OF THE BILL HR6331/S3101: MEDICARE IMPROVEMENTS FOR PATIENTS AND PROVIDERS ACT OF 2008; COMPARATIVE EFFECTIVENESS PROVISION COMPARATIVE EFFECTIVENESS ISSUES
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID NICHOLS | N/A |
| LYNN TAYLOR | N/A |
Budget/Appropriations BUD
S3230: LABOR, HEALTH AND HUMAN SERVICES APPROPRIATIONS; DRUG IMPORTATION ISSUES DRUG IMPORTATION ISSUES HOUSE CONCURRENT RESOLUTION 312: HOUSE BUDGET RESOLUTION; TITLES II, III, VI SENATE CONCURRENT RESOLUTION 70: SENATE BUDGET RESOLUTION; TITLE III, SECTIONS 306, 307, 326, 331, 333 HR 2642: 2008 SUPPLEMENTAL APPROPRIATIONS ACT; CHAPTER 4 - PROVISIONS TO INCREASE NATIONAL INSTITUTES OF HEALTH FUNDING FOR CANCER RESEARCH COMPARATIVE EFFECTIVENESS ISSUES
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID NICHOLS | N/A |
| LYNN TAYLOR | N/A |
Pharmacy PHA
S877: CONTROLLING THE ABUSE OF PRESCRIPTIONS ACT OF 2007; ALL PROVISIONS OF THE BILL HR4911: HUMAN GROWTH HORMONE RETRICTION ACT OF 2007; ALL PROVISIONS OF THE BILL DRUG IMPORTATION ISSUES HR1038/S623: ACCESS TO LIFE-SAVING MEDICINE ACT, FOLLOW-ON BIOLOGICS HR1956: PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINES ACT OF 2007; FOLLOW-ON BIOLOGICS PROVISIONS OF THE BILL HR5629: PATHWAY FOR BIOSIMILARS ACT; ALL PROVISIONS OF THE BILL S1505: AFFORDABLE BIOLOGICS FOR CONSUMERS ACT; FOLLOW-ON BIOLOGICS PROVISION OF THE BILL S1695: BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; FOLLOW-ON BIOLOGICS PROVISION OF THE BILL S2029: PHYSICIAN PAYMENTS SUNSHINE ACT OF 2007; ALL PROVISIONS OF THE BILL HR5839: THE SAFEGUARDING AMERICA'S PHARMACEUTICALS ACT OF 2008; ALL PROVISIONS OF THE BILL DRUG IMPORT SAFETY DRAFT
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID NICHOLS | N/A |
| LYNN TAYLOR | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.